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Abstract
Background: The essential role of copper in eukaryotic cellular physiology is known, but has not been recognized
as important in the context of influenza A virus infection. In this study, we investigated the effect of cellular copper
on influenza A virus replication.
Methods: Influenza A/WSN/33 (H1N1) virus growth and macromolecule syntheses were assessed in cultured human
lung cells (A549) where the copper concentration of the growth medium was modified, or expression of host genes
involved in copper homeostasis was targeted by RNA interference.
Results: Exogenously increasing copper concentration, or chelating copper, resulted in moderate defects in viral
growth. Nucleoprotein (NP) localization, neuraminidase activity assays and transmission electron microscopy did
not reveal significant defects in virion assembly, morphology or release under these conditions. However, RNAi
knockdown of the high-affinity copper importer CTR1 resulted in significant viral growth defects (7.3-fold reduced
titer at 24 hours post-infection, p = 0.04). Knockdown of CTR1 or the trans-Golgi copper transporter ATP7A
significantly reduced polymerase activity in a minigenome assay. Both copper transporters were required for
authentic viral RNA synthesis and NP and matrix (M1) protein accumulation in the infected cell.
Conclusions: These results demonstrate that intracellular copper regulates the influenza virus life cycle, with
potentially distinct mechanisms in specific cellular compartments. These observations provide a new avenue for
drug development and studies of influenza virus pathogenesis.
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Background
Influenza A remains a critical concern not only for
human health but also for wildlife health and the live-
stock industry. Seasonal human strains cause significant
mortality [1], and highly pathogenic avian viruses result
in flock loss as well as continuing to threaten new
human pandemics [2, 3]. While vaccination of human
populations is one available intervention, it is not com-
pletely effective and may not prevent the emergence
and spread of novel viruses. Application of antiviral
therapies is another approach to increase our readiness
for pandemic outbreaks. Antivirals such as oseltamivir,
which target viral processes, have shown utility, but
drug resistant viruses can emerge [4]. Antivirals that
target host processes important for the virus have po-
tential to circumvent the development of resistance,
and targeting of host processes has shown therapeutic
promise for other viruses [5]. Several specific host fac-
tors important for influenza replication have been iden-
tified, for example; the endosomal coat protein complex
(COP-I) and vacuolar ATPase regulate virion entry and
uncoating [6], RNA binding proteins are essential for
viral RNA synthesis [7], and karyopherins are involved
in nucleocytoplasmic transport of viral ribonucleopro-
tein (vRNP) [8]. Likewise, some host processes that
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regulate influenza A virus budding and release have
been identified. The F1Fo-ATPase was found to be
important for release of infectious virus particles [9],
while in contrast, virion release for some influenza A
virus strains is antagonized by histone deacetylase 6
[10] and the antiviral protein tetherin [11]. Discovery
of additional host processes involved in virion pro-
duction will provide additional options for therapy
development.
Copper handling machinery is evolutionarily con-
served throughout eukaryotes, and copper homeostasis
is recognized as important in human health. Copper
transport machinery has been identified as important in
macrophage antimicrobial responses [12]; however, little
is known about the role of copper related processes in
influenza infection. Copper is an important cofactor for
a number of critical cellular processes, including cellular
respiration and mitigation of oxidative stress. Many
additional copper-dependent processes are observed in
specific tissues, such as modulation of lipid metabolism
in the liver [13, 14], and neurotransmitter processing in
the brain [15, 16]. In the lung and respiratory tract,
extracellular matrix synthesis requires the copper-
containing enzyme lysyl oxidase [17]. Recent work has
further revealed altered expression of copper trans-
porters in response to pulmonary hypertension [18]. As
copper ions exist in two oxidative states, reduced Cu1+
(I) and oxidized Cu2+ (II), with different biological
activities, the cell maintains tight control of copper oxi-
dation and subcellular distribution through regulation
of highly conserved copper binding proteins and trans-
port machinery (for review, see [19]). This control is
mediated by a system of copper transporters and chap-
erones that direct copper ions, generally monovalent
Cu (I), to cellular compartments for physiological
functions. The copper transporter CTR1 (SLC31A1) is
important for uptake of copper ions, imported as Cu
(I), from the extracellular space [20]. CTR1 is
expressed in most tissues, and defects may be related
to disease conditions including Alzheimer’s disease
[21]. The copper transporter ATP7A is also expressed
in most cells, and transports Cu (I) ions from the cyto-
solic compartment into the trans-Golgi network, vesi-
cles, and eventually exports excess copper into the
extracellular space; defects in this gene are the cause of
Menkes disease [22]. ATP7A’s subcellular location is modi-
fied in response to different conditions, which is one mech-
anism in the maintenance of copper homeostasis [23].
Little is known about the role of copper and copper
dependent processes in influenza-infected cells. In an
RNAi based screen for host factors, knockdown of sev-
eral genes that regulate copper homeostasis including
CTR1 and ATP7A was reported to affect influenza
virus replication in human lung A549 cells [6],
suggesting a potential role for copper in viral replica-
tion. Additionally, studies have found that copper can
inactivate avian influenza particles on surfaces and
clothing [24, 25], and the copper dependent enzyme
SOD1 is important for influenza oxidative stress regu-
lation [26]. Further, the viral ion channel M2 was found
to be inhibited by copper ions in an oocyte based ex-
perimental system [27]. There are also some data that
indicate an effect of dietary copper on immune re-
sponse to influenza [28], which supports further inves-
tigation into the role of copper in influenza infection.
Perhaps the most telling research on the effect of intra-
cellular copper on the virus showed that thujaplicin-
copper chelates inhibited influenza induced apoptosis
and viral particle production in a tissue culture (MDCK
cells) model of infection [29].
To further investigate the influence of cellular cop-
per on influenza A virus replication, we tested the ef-
fect of altered copper environments on the viral life
cycle in a tissue culture model of lung cell infection.
We assessed the effects on the virus that result from
altering the amount of copper available to the cells, as
well as the effects from knocking down host genes re-
lated to copper homeostasis. We evaluated the impact
these treatments had on virus replication generally, as
well as on specific aspects of viral function. We
observed that altered copper concentration in the
growth medium and knockdown of host gene expres-
sion resulted in distinct viral replication defects. These
results begin to define the importance of cellular cop-
per metabolism in influenza processes, and indicate
the copper related pathways that show promise for
further investigation.
Methods
Cultured cells and virus
A549 lung adenocarcinoma cells and Madin-Darby
Canine Kidney (MDCK) cells were cultured in DMEM
(Corning Inc., Manassas, VA) supplemented with 10%
FBS (Atlas Biologicals, Fort Collins, CO).
Influenza A/WSN/33 (H1N1) virus stocks were
grown in MDCK cells, and titered by plaque assay on
MDCK cells [7]. The genome of our stock of WSN
was sequenced and compared to those recorded in the
Influenza Research Database. Two point mutations
were identified in our stock, which are not present in
the deposited sequences. In segment 6 (NA), a G to U
change at position 158 of the ORF results in a Ser to
Ile change at residue 53. In segment 7 (M), an A to G
change at position 502 of the ORF results in a Thr to
Ala change at residue 168. This latter change is known
[30] and does not alter virus growth characteristics in
cultured MDCK cells.
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Copper and chelator treatments
Cells were treated with 50 μM CuCl2 (Acros Organics,
Morris Plains, NJ) or 10 μM ammonium tetrathiomo-
lybdate (TTM; Sigma-Aldrich, St. Louis, MO) by sup-
plementing normal growth medium and inoculums,
beginning at 24 hours prior to subsequent treatments,
i.e. infection. TTM is an efficient intracellular copper
chelator [31, 32]. Intracellular copper concentrations in
complete lysates of untreated, 10 μM TTM, and 50 μM
CuCl2 treatment of A549 cells were assessed by induct-
ively coupled plasma mass spectrometry (ICP-MS)
elemental analysis (courtesy of M. Ralle, Oregon Health
& Science University). Cytotoxicity of CuCl2 and TTM
on cell viability was assayed by chemiluminescent ATP
quantitation; CellTiter-Glo (Promega, Madison, WI).
No decrease in luminescence was observed below con-
centrations of CuCl2 or TTM at least 5 fold higher than
used for this study. Additionally, the possible effect of
these treatments on virion viability was assayed. Copper
ions have previously been seen to inactivate H9N2
virions [24]. To determine if such inactivation was oc-
curring in our conditions, inoculums were prepared as
for infections and incubated in the presence of CuCl2
or TTM but without cells. No effect on titer was ob-
served at the concentrations used for this study.
RNAi knockdowns
Expression of cellular copper transport genes in A549 cells
was reduced by transfection with endoribonuclease-
prepared siRNAs (esiRNAs). Transfection mixes were pre-
pared with Lipofectamine RNAiMax (Life Technologies,
Carlsbad, CA) and 5 to 20 nM of siRNA Universal
Negative Control, MISSION esiRNA human CTR1
(SLC31A1), or MISSION esiRNA human ATP7A
(Sigma-Aldrich, St. Louis, MO). Cells were seeded onto
mixes 36 hours prior to infection.
MISSION esiRNAs (Sigma-Aldrich) comprise a multi-
plex pool of siRNA that target a specific mRNA se-
quence, leading to highly specific gene silencing [33].
The effect of knockdowns on cell viability was assessed,
as for CuCl2 or TTM treatments above, by CellTiter-
Glo. Experimental esiRNA concentrations were chosen
such that cell viability, as determined by this assay, was
equivalent to the negative control siRNA knockdown.
Knockdown efficiencies were validated by quantitative
reverse-transcriptase–PCR (qRT-PCR) with primers
specific to the target gene. For both esiRNAs, the target
transcript levels were reduced by around 90% relative
to the negative control siRNA knockdown (data not
shown).
Viral RNA quantification
Control A549 cells and those treated with either Cu,
TTM or esiRNA were infected at multiplicity of
infection (MOI) = 1, and at the indicated times were
washed with phosphate buffered saline (PBS). Lysates
were harvested in buffer RLT and RNAs extracted by
RNeasy kit (Qiagen, Valencia, CA). Viral RNA was
quantified by qRT-PCR, using SYBR green based detec-
tion. Reverse-transcription and PCR reactions were per-
formed in one tube with the iTaq kit (BioRad, Hercules,
CA), in a BioRad CFX96 thermocycler. Primers for the
viral RNA were specific to the nucleoprotein (NP) gene
(segment 5). Similar results were obtained with primers
specific to the M gene (segments 7), thus we present
the representative NP data. Primers specific to 18S
rRNA were used as the reference, and relative expres-
sion was calculated using the 2^(−Delta Delta C(T))
method [34]. Statistical significance was assessed by
paired two-tailed t-test, p < 0.05.
Viral minigenome assay
Viral polymerase activity was assessed using an experi-
mentally optimized minigenome assay with viral poly-
merase expression vectors (VPOL: pCAGGS-NP and
pCAGGS-PB1, −PB2, and -PA, in a 5:2:1:2 ratio), a
vRNA firefly luciferase reporter construct (minigenome),
and Renilla luciferase expression plasmid as an internal
transfection control, as we described previously [7].
A549 cells were transfected with esiRNA and incubated
for 36 hours. Cells were then transfected with VPOL,
minigenome, and Renilla plasmids, using the FuGENE
HD transfection reagent (Promega), following the manu-
facturer’s recommendations. 24 hours after the second
transfection, cells were harvested and assayed using the
Dual Luciferase Reporter Assay (Promega) on a BioTek
Synergy HT reader.
Viral protein quantification
Proteins were extracted from the same samples har-
vested for viral RNA quantification, above. Extractions
from buffer RLT were performed using the iced acet-
one method described by the manufacturer (Qiagen).
Proteins were separated by denaturing SDS polyacryl-
amide gel electrophoresis, and transferred to PVDF
(Pall Corp., Pensacola, FL). Immunoblotting was per-
formed with monoclonal antbody to influenza NP
(AA5H; AbCam, Cambridge, MA) or anti-M1 poly-
clonal (a kind gift of Dr. Adolfo García-Sastre, Icahn
School of Medicine at Mount Sinai), and peroxidase
conjugated secondary antiserum. Blots were imaged
with Supersignal substrate (ThermoFisher Scientific,
Carlsbad, CA), on a Cell Biosciences FluorChem HD2.
Consistent loading was monitored by Coomassie Bril-
liant Blue R-250 (Amresco, Solon, OH) staining of the
post-transfer gel.
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Viral growth kinetics and neuraminidase activity
Control A549 cells and those treated with either Cu,
TTM or esiRNA were infected at MOI = 1. Culture
medium was sampled and replaced at 12-hour intervals.
The titer of infectious particles was quantified by immu-
nostaining in MDCK cells as follows: inocula were pre-
pared by tenfold serial dilution of the samples, and
subconfluent MDCK monolayers in 96 well plates were
infected. After 8 hours, cells were fixed in 4% parafor-
maldehyde in PBS, and permeabilized with 0.1% NP-40
in PBS. Membranes were blocked with 1% non-fat dry
milk, then probed with antiserum to the NP protein and
a fluorescently tagged secondary antiserum, and fluores-
cent foci counted. Total counts of each well were taken,
for at least two dilutions per sample. Dilutions showing
between 5 and 500 fluorescent foci were chosen, and the
fluorescent forming units (FFU) per mL calculated as an
average from these multiple counts.
Neuraminidase (NA) activity in the harvested medium
was quantified by NA-Fluor kit (Applied Biosystems,
Foster City, CA). Serial dilutions of samples were com-
bined with an equal volume of substrate working solu-
tion, and incubated 60 minutes. The stop solution was
added and fluorescence determined in a BioTek Synergy
HT reader. Fluorescence values were normalized to the
titer of each sample.
Immunofluorescence microscopy
CuCl2 concentrations were 10 μM for this experiment.
Treated A549 cells were infected at MOI = 1. At 12 hours
post infection (h.p.i.), cells were washed with PBS, fixed
in 4% paraformaldehyde, and permeabilized with 0.1%
saponin. Samples were probed with primary antisera
using sheep anti-TGN46 (Serotec), rabbit anti-ATP7A (a
gift from S. Lutsenko), or anti-NP monoclonal AA5H, in
PBS with 0.05% Tween 20 and 3% bovine serum albu-
min. Secondary antisera conjugated to Alexa Fluor 488,
532, or 647 were used for visualization, and mounted in
VectaShield with DAPI (Vector Laboratories, Burlin-
game, CA). Images were captured at room temperature
with a Leica DM6000 B microscope with a 63x oil
immersion objective, numerical aperture = 1.4, and a
Photometrics (Tucson, AZ) CoolSNAP MYO camera.
Software for capture and deconvolution was Leica Appli-
cation Suite X (LAS X) and image placement Adobe
Illustrator.
Transmission electron microscopy
Treated A549 cells were infected at MOI = 5. At
16 h.p.i., cells were washed with PBS and fixed in 2.5%
glutaraldehyde (Electron Microscopy Sciences, Fort
Washington, PA) and 0.1 M cacodylate, pH 7.4. Cells
were then embedded in Eponate 12 resin, cut into 80-
nm sections, and stained with 5% uranyl acetate and 2%
lead citrate at the Emory Robert P. Apkarian Integrated
Electron Microscopy Core. After sample preparation,
grids were imaged at 75 kV using a Hitachi H-7500
transmission electron microscope.
Results and discussion
Processes in cellular copper metabolism overlap with the
influenza virus lifecycle. To study their relationship, if
any, we examined the effect of the intracellular copper
concentration on influenza A replication. Using the hu-
man lung epithelial adenocarcinoma cell line A549;
intracellular copper (I) concentration was raised by sup-
plementing the growth medium with 50 μM CuCl2, or
lowered by supplementing with 10 μM of copper chela-
tor TTM. TTM decreases the bioavailable copper [35],
which promotes trans-Golgi localization of the copper
exporter ATP7A [36]. As expected, intracellular copper
concentration relative to protein content in A549 cell
extracts was approximately 15-fold higher for 50 μM
CuCl2 treatment, and 3-fold lower for 10 μM TTM
treatment, in comparison to untreated A549 cells, as
measured by ICP-MS elemental analysis (Table 1).
Treated cells were then infected with influenza A/
WSN/33 (H1N1). Viral growth in cells with altered
copper levels was assessed by measuring infectious
particles released at 12 hour intervals (Fig. 1a). Alter-
ation of physiological copper concentration in A549
cells resulted in a moderate reduction in the titer of
virus produced late in the virus lifecycle, both under
10 μM of chelator TTM at 24 hours post infection
(h.p.i.) (p = 0.051) and 36 h.p.i. (p = 0.005), and 50 μM
of exogenous CuCl2 at 36 h. p.i. (p = 0.038) treatment
(Fig. 1a). These data suggest that the homeostatic bal-
ance of copper ions in host cells is important in the









Media 0.663 4.0 1.0
10 μM TTM 0.686 1.2 0.3
50 μM CuCl2 0.144 12.9 14.8
Negative Control siRNA 0.680 2.7 1.0
CTR1 esiRNA 0.472 1.6 0.9
ATP7A esiRNA 0.502 18.2 9.1
aA549 cells were untreated (Media), treated with 50 μM CuCl2 or 10 μM
ammonium tetrathiomolybdate (TTM), or transfected with indicated siRNA for
24 hours, washed in PBS and lysed in RIPA buffer
bProtein measured by BCA assay
cElemental analysis of total intracellular copper (ionized to Cu2+) by inductively
coupled plasma mass spectrometry (ICP-MS)
dIntracellular Cu was normalized to protein content for control conditions of
Media alone (χ2 < 0.001), or Negative Control siRNA (χ2 < 0.001), expressed as a
ratio to each control condition, respectively; χ2, chi-squared test against
null model
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viral life cycle. To further assess this effect, viral RNA
accumulation was assayed in treated cells early and
late in infection (Fig. 1b). In this assay, increased cop-
per did not have a significant effect on viral RNA
levels. TTM chelator treatment did display a trend of
lower RNA levels at 12 h.p.i. (p = 0.09), but differences
in RNA levels were not significant at later time points
or for CuCl2 treatment. Thus in both treatments the
level of viral RNA in treated cells weakly correlated
with the decreased titers observed. To assess effects
on viral protein levels, treated cells were harvested at
12 h.p.i. and viral nucleoprotein (NP) levels assessed
by western blotting. While less NP protein accumu-
lated under TTM chelator treatment (Fig. 1c), similar
to the trend observed with viral RNA synthesis
(Fig. 1b), the difference paralleled a significant reduc-
tion in infectious titer (Fig. 1a). Viral macromolecular
synthesis or accumulation appears less affected than
infectious particle production, suggesting that copper-
binding host proteins in the cell retain their copper
under TTM or CuCl2 treatment, and function rela-
tively normally in the early stages of infection. Thus,
the defect caused by altering cellular copper with




Fig. 1 Addition of copper or chelator inhibits viral growth but not macromolecular accumulation. A549 cells’ growth medium was supplemented
with 50 μM CuCl2 or 10 μM TTM, to alter intracellular copper concentration, 24 hours before infection with influenza A/WSN/33 (H1N1). (a) At the
indicated times post infection, infectious particles released into the medium were determined by immunostain assay. A representative data set is
shown (i), with mean and standard deviation from the control condition for 3 independent experiments shown in accompanying panel (ii).
Titer = fluorescent center forming units per mL. (b) At the indicated times cells were lysed and RNA extracted. Relative viral RNA amounts
were determined by qRT-PCR with primers for the NP (segment 5) RNA and the host 18S rRNA. The means of two technical replicates are displayed
as points, with the mean and standard deviation of three biological replicates indicated with whiskers. (c) At 12 h.p.i. cells were lysed and
proteins extracted. Proteins were subjected to western blotting using antisera to the viral NP protein. A representative blot of at least 3
independent experiments is shown. After transfer the gels were stained with coomassie blue; a section is shown as loading control
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in part, efficient assembly and release of new particles.
Additionally, fluorescent centers appeared to cluster
more in virus preparations from treated cells, an ob-
servation that also supports an assembly phenotype
(data not shown).
To further assess the effect of copper metabolic path-
ways on influenza infection, we examined the require-
ments for genes central to copper homeostasis by RNAi
knockdown. Viral replication was assayed in cells trans-
fected with endoribonuclease-prepared siRNA (esiRNA)
pools [33] to ablate transcripts encoding the copper im-
porter CTR1 or copper transporter ATP7A. In A549
cells targeted by RNAi, intracellular copper was 9-fold
higher in ATP7A knockdown (Table 1), consistent with
impaired Cu efflux through the secretory pathway;
CTR1 knockdown only mildly decreased total intracellu-
lar Cu, although intracellular copper distribution could
not be assessed. Knockdown of ATP7A resulted in
mildly depressed virus production (1.4-fold decrease,
p = 0.05) only late in infection (36 h.p.i.), However,
CTR1 knockdown resulted in marked decrease in in-
fectious particles released by 24 h.p.i. (7.3-fold, p =
0.04,) with significant reduction persisting at 36 h.p.i.
(p = 0.013) (Fig. 2a). CTR1 knockdown exhibited a
mild but not significant decrease in titer early in infec-
tion (12 h.p.i., p = 0.13). Efficiency of knockdown of
ATP7A and CTR1 transcripts and protein, in compari-
son to nontarget siRNA control, were analyzed by
quantitative RT-PCR (Fig. 2b) and immunofluores-




Fig. 2 Knockdown of host copper homeostasis genes affects viral growth. A549 cells were transfected with esiRNAs 48 hours before infection
with influenza A/WSN/33 (H1N1). (a) At the indicated times post infection, infectious particles released into the medium were determined by
immunostain assay. A representative data set is shown (i), with mean and standard deviation from the control condition for 3 independent
experiments shown in accompanying panel (ii). Titer = fluorescent center forming units per mL. (b) Total cellular RNA was harvested, and ATP7A
and CTR1 transcripts quantified by qRT-PCR and normalized to 18S rRNA reference by ΔΔCt method. (c) ) Immunofluorescence microscopy
evaluating knockdown depletion and subcellular localization of ATP7A and CTR1 in uninfected A549 cells; DAPI, blue; TGN46, magenta; CTR1,
green (ii); ATP7A, green (ii). Scale bar, 10 μm
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that copper transporter-mediated distribution of intra-
cellular copper is necessary for sustaining efficient
viral replication.
To understand the necessity for copper transport in
earlier stages of infection, we analyzed viral RNA and
protein syntheses in cells targeted by knockdown of
CTR1 or ATP7A copper transporters (Fig. 3). CTR1
knockdown significantly reduced viral RNA synthesis
(4 h.p.i, p = 0.006), as did ATP7A at this timepoint (p =
0.007). Viral RNA synthesis significantly lagged in CTR1
knockdown (12 h.p.i, p = 0.06; 24 h.p.i, p = 0.01), while
knockdown of ATP7A did not produce a significant ef-
fect after 4 h.p.i. (Fig. 3a). These data suggested that
copper distribution in the cell is necessary for viral RNA
synthesis. To study whether copper transporters affect
activity of the influenza A viral RNA-dependent RNA
polymerase complex, we assayed viral polymerase activ-
ity in the absence of other viral processes, using a mini-
genome reporter assay (Fig. 3b). In alignment with
reduced RNA synthesis during intact viral infection
(Fig. 3a), viral polymerase activity was drastically re-
duced (p < 10−7) by knockdown of either CTR1 or
ATP7A (Fig. 3b). In parallel to decreased viral RNA syn-
thesis, in infected cells, synthesis of viral nucleoprotein
(NP) (Fig. 3c) and matrix protein (M1) (Fig. 3d) were
both markedly reduced by knockdown of either CTR1
or ATP7A. Interestingly, ATP7A knockdown caused





Fig. 3 Knockdown of host copper homeostasis genes affects viral macromolecular accumulation. (a) At the indicated times cells were lysed and
RNA extracted. Relative viral RNA amounts were determined by qRT-PCR with primers for the NP (segment 5) RNA and the host 18S rRNA. The
means of two technical replicates are displayed as points, with the mean and standard deviation of three biological replicates indicated with
whiskers. (b) esiRNA treated cells were transfected with VPOL, firefly luciferase minigenome, and Renilla luciferase expression vectors. Relative viral
RNA replication was assessed by normalizing firefly luciferase activity to Renilla luciferase activity. Biological replicates are displayed as points, with
the mean and standard deviation of six biological replicates indicated with whiskers. (c and d) At 12 h.p.i. cells were lysed and proteins extracted.
Proteins were subjected to western blotting using antisera to (c) viral NP protein, or (d) viral M1 protein. Relative viral proteins in knockdown
immunoblots were quantified by densitometry. After transfer, gels were stained with Coomassie Brilliant Blue; a section is shown as loading control
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synthesis than overall infectious particle production,
suggesting that viral RNA and proteins are produced in
excess in A/WSN/33 (H1N1) infection of A549 cells
while copper transport is necessary for efficient virion
production.
We found these results intriguing. In experiments
where copper concentration was altered by copper che-
lator TTM , or adding exogenous CuCl2 a larger effect
was observed on infectious particles released than on
RNA and protein levels (Fig. 1). RNA and protein levels
were however affected by knockdown of copper trans-
porters, with concomitant reduced RNA (Fig. 3a) and
protein (Fig. 3c, d) syntheses, upstream of an observed
decrease in titer (Fig. 2a). Thus, we sought to further
understand how changing total copper concentration
might affect late steps in the viral lifecycle, i.e. virion as-
sembly, maturation, and release. Neuraminidase (NA),
the viral glycoprotein that facilitates release from the
mother cell, undergoes maturation and export through
the Golgi network. CuCl2 and TTM treatments likely
affect copper concentrations within the Golgi, possibly
affecting glycoprotein maturation and function such as
the disulfide bonding required for NA function [37]. The
amount of NA activity was assayed in particles released
from cells treated with CuCl2 and TTM (Fig. 4a). A
small increase in NA activity per infectious unit of virus
was observed in particles produced by cells treated with
exogenous CuCl2 (p = 0.03), but not with TTM copper
chelator. This suggests that virion-associated neuramin-
idase enzyme activity is in part dependent on copper in
the host cells. We have not ruled out a redox-related
mechanism whereby exogenous CuCl2 treatment leading
to excess Cu (I) in the cell (Table 1) could affect redox
potential, and thus glycoprotein processing, in the
secretory pathway. Future work will evaluate copper’s ef-
fect on the oligomerization/disulfide bond formation
[38], protease cleavage [39], glycosylation [40], and traf-
ficking of virion glycoproteins to the apical cell surface
[41].
Also having observed reduced virus titers when copper
concentrations were altered (Fig. 1), we hypothesized
that virion assembly or morphology could be copper-
dependent. To further analyze effects on assembly, the
budding of virions from the plasma membrane was visu-
alized. Cells were again treated with CuCl2 or TTM and
infected with influenza A/WSN/33 (H1N1), then fixed
and imaged by transmission electron microscopy (TEM).
Although we had observed a quantifiable difference in
infectious particle production under CuCl2 or TTM
treatment (Fig. 1a), no significant differences in virion
Fig. 4 Alteration of copper does not disrupt virion neuraminidase activity or particle morphology. A549 cells were untreated (Naught) or treated
24 hours with 50 μM CuCl2 or 10 μM TTM before infection with influenza A/WSN/33 (H1N1) virus (MOI = 1). (a) Extracellular virus was harvested
from cell supernatants 48 h.p.i. and analyzed by fluorescent substrate-based neuraminidase assay. Relative fluorescent units were normalized to
the number of plaque forming units (PFU) in each sample. The means of 6 technical replicates are displayed as points, with the mean and standard
deviation of three biological replicates indicated with whiskers. (b) Cells were fixed 12 h.p.i. for transmission electron microscopy (TEM) analysis of viral
particles budding from plasma membrane; (i) no treatment (Naught), (ii) 10 μM TTM, (iii) 50 μM CuCl2. Scale bar, 200 nm
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particle morphology and budding were noted (Fig. 4b).
Spherical (100 nm diameter) and oblong (100-200 nm
longitudinal axis) virus particles containing viral ribo-
nucleoptoein (vRNP) segments were predominantly
observed budding from untreated cells infected with
A/WSN/33 (H1N1) virus (Fig. 4b), as well as a minor-
ity of filamentous particles (>200 nm longitudinal axis,
<1%). In cells treated with CuCl2 or TTM prior to
WSN infection, no observable differences were appar-
ent in gross virion particle morphology. Thus, altering
intracellular copper concentration apparently leads to
less efficient virion formation (i.e., lower titer), rather
than a defect in virion morphology. NA activity is
known to be a determinant of particle morphology,
with increased neuraminidase activity observed on
filamentous virions [42]. As virion NA activity was in-
creased in exogenous copper treatment (Fig. 4a), we
might also have expected a shift in the observed
sphere-to-filament ratio. However, fewer distinct fila-
mentous particles were visible budded from cells
treated with CuCl2, although the difference in fre-
quency was not significant. As influenza A/WSN/33
(H1N1) virus infection in cultured cells does not
produce significant numbers of filamentous particles,
further investigation of the possible role of copper in mat-
uration of filamentous influenza A virions will require
analyses of filamentous-producing virus, such as those
harboring mutations in matrix proteins M1 [30, 42] or M2
[43].
To study how intracellular copper transport might
regulate influenza virion proteins, viral nucleoprotein
(NP) and copper transporter ATP7A were analyzed by
immunofluorescence. Early in infection, NP can be
found in the cell nucleus, later translocating to the
cytoplasm with vRNP during virion assembly stages [7].
In concordance with intact virion assembly (Fig. 4b),
infected cells showed little difference in punctate NP
distribution in the cytoplasm at 12 h.p.i. under no treat-
ment, exogenous CuCl2 or TTM treatments (Fig. 5a).
As previously observed in other cell types [36], ATP7A
is a membrane-associated transporter protein that lo-
calized to a vesicular cytoplasmic compartment that
partly overlapped with trans-Golgi protein TGN46
(Fig. 2c), a pattern maintained after TTM treatment or
exogenous CuCl2 treatment (Fig. 5b). While ATP7A did
not fully co-localize with trans-Golgi marker TGN46,
a
b
Fig. 5 Localization of influenza nucleoprotein and copper transporter ATP7A in infected cells treated with exogenous copper of chelator. (a)
A549 cells were untreated (Mock) or treated 24 hours with 50 μM CuCl2 or 10 μM TTM before infection with influenza A/WSN/33 (H1N1) virus
(MOI = 1). Cells were fixed 12 h.p.i. for immunofluorescence microscopy to analyzing subcellular localization of NP. DAPI, blue; NP, green. Scale
bar, 10 μm. (b) Immunofluorescence microscopy analyzing subcellular localization of ATP7A after CuCl2 or TTM at 12 h.p.i. DAPI, blue; TGN46,
magenta; NP, red; ATP7A, green. Scale bar, 10 μm
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influenza A virus infection altered localization of
ATP7A. ATP7A appeared in a dispersed vesicular pat-
tern in the cytoplasm in infected cells treated with ex-
ogenous copper, but in a more concentrated pattern
reminiscent of nuclear-proximal Golgi under TTM
treatment (Fig. 5b). These results suggest that influenza
A virus may disrupt copper-responsive trafficking of
ATP7A in the cell secretory pathway. It is important to
note that other viral proteins traffic through the cyto-
plasm during virion assembly. M2 functions to prevent
acidification of Golgi lumen, which could prematurely
trigger hemagglutinin (HA) conformational rearrange-
ment [44, 45]. Copper is trafficked through the Golgi in
a number of conditions, and HA glycoprotein process-
ing or NA maturation could be affected by altered cop-
per related conditions, in addition to potential effects
on M2 as noted previously [27]. How intracellular cop-
per distribution, and localization of copper transporter
proteins including ATP7A might affect trafficking and
maturation of viral proteins, and ultimately virus repli-
cation, is under further investigation.
Cellular compartments where viral life cycle and cop-
per transport overlap are summarized in Fig. 6. Entry of
influenza particles into the cell, mediated by the HA,
NA, and M2 proteins, involves interactions at the cell
surface and fusion and uncoating from the endosome.
These processes have the potential be affected as endo-
cytosis can be affected by copper concentration [46], and
ion concentrations are important for influenza’s entry
steps [47]. Compartmentalized copper has been found to
inhibit ion transport activity of viral M2 protein [27];
thus, intracellular copper distribution could also affect
uncoating of entering virions. Viral RNA is synthesized
in the cell nucleus, and viral proteins are synthesized in
the cytosol. We found that the restriction of copper ions
by knockdown of either CTR1 or ATP7A grossly affects
viral RNA and protein syntheses in the nucleus and
cytoplasm, respectively (Fig. 3). Intracellular copper dis-
tribution is tightly regulated by CTR1, importing copper
into the cell, affecting the biological activity of chaper-
ones such as ATOX1 that in turn regulate functions of
cytoplasmic and nuclear host proteins, as well as ATP7A
(Fig. 6). Disruption of the trans-Golgi copper importer
ATP7A that regulates compartmentalized copper distri-
bution may lead to accumulation of copper in the cyto-
plasm or disruption in other compartments (Fig. 6).
However, increased expression of other copper trans-
porters, for example ATP7B, may be induced when
copper homeostasis is disrupted [48, 49], resulting in
compensatory redistribution of intracellular copper.
Thus, disruption of copper transport in infected cells
may influence copper homeostasis, and the virus life
cycle in a compartment-specific manner,
We expected the down-regulation of CTR1 to result in
an intracellular environment similar to chelator (TTM)
treatment, i.e. lower available copper. However, knock-
down of CTR1 or ATP7A (Fig. 2 and Fig. 3) had a more
dramatic effect on viral replication than the chelator
(Fig. 1). CTR1 inhibition results in a mild reduction in
available copper, and ATP7A knockdown results in cop-
per accumulation in the cells (Table 1). Disruption of
these proteins likely changes in copper availability and
possibly redox potential in subcellular compartments.
ATP7A transports copper ions from the cytosol to
Fig. 6 Model of copper-mediated regulation of the influenza virus life cycle. Extracellular copper [Cu2+] shares topological space with virion
binding to host cell, and viral entry steps within the endosome. CTR1 imports extracellular copper to the cytoplasm. Intracellular copper [Cu1+]
is associated with the ATOX1 chaperone and other metalloproteins. From there, copper is actively transported into the secretory pathway by
ATP7A. ATP7A plays a role determining copper concentration in the cytosol and in ER, Golgi, and other membrane bound compartments,
where the viral glycoproteins HA and NA (o) are synthesized and mature. New viral RNA are synthesized in the nucleus, where ATOX1 may transport
intracellular [Cu1+]. In complex with matrix proteins (M1 and M2, ☐), genomic viral RNA progeny are exported from the nucleus to associate with M1,
M2, HA, NA and other proteins to assemble budding virions at the plasma membrane, a site that is topologically in the cytosol
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compartments including the Golgi network and vesicles,
serving a biosynthetic role for the secretory pathway and
copper export role to maintain cellular copper balance
[48, 49]. It can be reasoned that in infected cells,
ATP7A-mediated transport of Cu (I) is required for ef-
ficient viral RNA and viral protein syntheses (Fig. 3).
We expected the effect of ATP7A knockdown would
resemble that of increased exogenous CuCl2, leading to
increased cytoplasmic copper but disrupted copper
homeostasis in other cellular compartments that de-
pend on ATP7A for copper import (Fig. 6). In parallel,
maturation of viral glycoproteins and disulfide shuffling
[50] occurs during through the Golgi network, a com-
partment dependent on ATP7A import of copper.
Thus, initially we had expected an ATP7A-dependent
viral replication defect might be at an entry or exit step.
However, the results suggest ATP7A regulates synthesis
of viral RNA and protein macromolecules, nuclear and
cytosolic steps in the virus life cycle that are highly
dependent on host factors [7].
Conclusions
Viral processes are intimately entwined with host func-
tions. Copper metabolism is important in a number of
host functions, with diet and therapeutics under inves-
tigation for several genetic and developmental defects
in rodent models [14, 51]. Here we show that cellular
copper homeostasis is linked to the influenza A virus
life cycle. This study showed that host proteins that
transport copper into the cell (CTR1) and into the
secretory pathway (ATP7A) are required for influenza
A/WSN/33 (H1N1) RNA and protein syntheses. These
data suggest that copper has specific roles in viral repli-
cation in the cytoplasm as well as in viral protein inter-
actions with the secretory pathway. Further research
into this relationship will help to define additional as-
pects of influenza processes, and may offer additional
avenues for anti-influenza therapy development.
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